AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Malin Corporation Plc

Report Publication Announcement Mar 13, 2019

1959_rns_2019-03-13_e06b966b-461a-4f13-9fc3-828d06d9529d.html

Report Publication Announcement

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6680S

Malin Corporation PLC

13 March 2019

Malin Corporation plc

Notice of Full Year 2018 Results, Publication of 2018 Annual Report and 2019 AGM

Dublin-Ireland, 13 March 2019: Malin Corporation plc. (Euronext Growth Dublin:MLC) ("Malin", the "Company"), a company investing in highly innovative life sciences companies, announces that it will report its results and publish its annual report for the year ended 31 December 2018 on Tuesday, 2 April 2019.

A conference call for analysts and investors will be held at 12:00pm Irish Standard Time/BST on the day of publication. The call will be hosted by Darragh Lyons, Chief Business & Financial Officer and Ian Curley, Executive Chairman, and will include a Q&A session.

Details of the conference call will be provided in the results statement and will be uploaded to the Company's website on Tuesday, 2 April 2019.

Malin's 2019 Annual General Meeting ("AGM") will be held at The Royal Marine Hotel, Dun Laoghaire, Co. Dublin, Ireland at 10:00am Irish Standard Time/BST on Thursday, 9 May 2019.

The Notice of AGM and Form of Proxy will be dispatched to all shareholders, and an electronic copy of the Notice of AGM will be available on the Company's website over the coming weeks.

ENDS

About Malin Corporation plc

Malin (Euronext Growth Dublin:MLC) is a company investing in highly innovative life sciences companies. Its purpose is to create shareholder value through the application of long-term capital and operational and strategic expertise to a diverse range of global healthcare businesses. Malin has a focus on innovative businesses underpinned by exceptional science and works with its investee companies, providing strategic and financial support to enable them to reach their value potential. Malin is headquartered and domiciled in Ireland and listed on the Euronext Growth Dublin. For more information visit www.malinplc.com 

For further information, please contact:

Malin

Jessica Bergin, Director of Investor Relations & External Reporting

Tel: +353 (0)1 901 5700

[email protected]

Consilium Strategic Communications

Mary-Jane Elliott / Jessica Hodgson

Tel: +44 (0)20 3709 5700

[email protected]

Powerscourt (Irish media enquiries)         

Eavan Gannon                                              

Tel: +353 87 236 5973                            

[email protected]              

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

MSCSFWEEEFUSEED

Talk to a Data Expert

Have a question? We'll get back to you promptly.